Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Arthritis & Rheumatology (Hoboken, N.J.)|March 30, 2023
Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile MyositisMatthew A Sherman, Katherine Pak, Iago Pinal-Fernandez, et al.Annals of Surgery|November 5, 2016
Molecular Characterization of Hypoxic Alveolar Epithelial Cells After Lung Contusion Indicates an Important Role for HIF-1αMatthew A Sherman, Madathilparambil V Suresh, Vladislav A Dolgachev, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and MortalityMatthew A Sherman, Payam Noroozi Farhadi, Katherine Pak, et al.Pediatric Rheumatology Online Journal|January 7, 2023
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research AllianceMatthew A Sherman, Hanna Kim, Katelyn Banschbach, et al.Pediatric Rheumatology Online Journal|July 31, 2023
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational studyBrian L P Dizon, Christopher Redmond, Emily C Gotschlich, et al.Critical Care Medicine|August 11, 2016
Double-Stranded RNA Interacts With Toll-Like Receptor 3 in Driving the Acute Inflammatory Response Following Lung ContusionMadathilparambil V Suresh, Bivin Thomas, David Machado-Aranda, et al.Rheumatology (Oxford, England)|August 12, 2022
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease featuresMatthew A Sherman, Rose Graf, Sara E Sabbagh, et al.Rheumatology (Oxford, England)|February 10, 2025
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providersMatthew A Sherman, Rebecca Nicolai, Emily K Datyner, et al.Arthritis Care & Research|June 27, 2024
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile DermatomyositisStacey E Tarvin, Matthew A Sherman, Hanna Kim, et al.JCI Insight|November 25, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trialMeggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.Pageof 3